1. Home
  2. EARN vs BIOA Comparison

EARN vs BIOA Comparison

Compare EARN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • BIOA
  • Stock Information
  • Founded
  • EARN 2012
  • BIOA 2015
  • Country
  • EARN United States
  • BIOA United States
  • Employees
  • EARN N/A
  • BIOA N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EARN Real Estate
  • BIOA Health Care
  • Exchange
  • EARN Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • EARN 187.6M
  • BIOA 162.0M
  • IPO Year
  • EARN 2013
  • BIOA 2024
  • Fundamental
  • Price
  • EARN $5.90
  • BIOA $4.20
  • Analyst Decision
  • EARN Hold
  • BIOA Hold
  • Analyst Count
  • EARN 1
  • BIOA 4
  • Target Price
  • EARN N/A
  • BIOA $6.33
  • AVG Volume (30 Days)
  • EARN 758.7K
  • BIOA 145.9K
  • Earning Date
  • EARN 03-12-2025
  • BIOA 03-18-2025
  • Dividend Yield
  • EARN 16.27%
  • BIOA N/A
  • EPS Growth
  • EARN N/A
  • BIOA N/A
  • EPS
  • EARN 0.28
  • BIOA N/A
  • Revenue
  • EARN $15,069,000.00
  • BIOA N/A
  • Revenue This Year
  • EARN N/A
  • BIOA N/A
  • Revenue Next Year
  • EARN $89.08
  • BIOA N/A
  • P/E Ratio
  • EARN $21.12
  • BIOA N/A
  • Revenue Growth
  • EARN N/A
  • BIOA N/A
  • 52 Week Low
  • EARN $5.78
  • BIOA $3.85
  • 52 Week High
  • EARN $7.26
  • BIOA $26.62
  • Technical
  • Relative Strength Index (RSI)
  • EARN 18.43
  • BIOA N/A
  • Support Level
  • EARN $6.30
  • BIOA N/A
  • Resistance Level
  • EARN $6.46
  • BIOA N/A
  • Average True Range (ATR)
  • EARN 0.12
  • BIOA 0.00
  • MACD
  • EARN -0.05
  • BIOA 0.00
  • Stochastic Oscillator
  • EARN 15.37
  • BIOA 0.00

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

Share on Social Networks: